Expert meeting on clinical investigation of new drugs for the treatment of chronic hepatitis C in the paediatric population

Date: 04/04/2011
Location: European Medicines Agency, London
The objective of the meeting is to discuss the clinical development of new drugs for the treatment of chronic hepatitis C in the paediatric population, taking into consideration possible differences between the adult and paediatric population in particular in terms of safety and possibility to extrapolate efficacy from the adult data.

How useful was this page?

Add your rating